v3.25.2
Loss Per Common Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Earnings Per Share [Abstract]        
Income (loss) before preferred dividends and accretion of Series A Preferred Stock $ (19,897) $ 1,596 $ (84,515) $ (15,684)
Dividends and accretion of Series A Preferred Stock (31,193) (7,979) (38,825) (15,924)
Net loss attributable to common shareholders of Evolent Health, Inc. - basic (51,090) (6,383) (123,340) (31,608)
Net loss attributable to common shareholders of Evolent Health, Inc. - diluted $ (51,090) $ (6,383) $ (123,340) $ (31,608)
Weighted-average common shares outstanding - basic (in shares) 115,882 114,688 115,600 114,415
Weighted-average common shares outstanding - diluted (in shares) 115,882 114,688 115,600 114,415
Basic and diluted        
Basic (in dollars per share) $ (0.44) $ (0.06) $ (1.07) $ (0.28)
Diluted (in dollars per share) $ (0.44) $ (0.06) $ (1.07) $ (0.28)